Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
Clinical trial NCT03092232 · COMPLETED
Trial details
- NCT number
- NCT03092232
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-16
- Primary completion
- 2017-07-13
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.